-
1
-
-
2542500611
-
The biology of CML blast crisis
-
DOI 10.1182/blood-2003-12-4111
-
B Calabretta D Perrotti 2004 The biology of CML blast crisis Blood 103 4010 4022 10.1182/blood-2003-12-4111 14982876 1:CAS:528:DC%2BD2cXkvVyisb8%3D (Pubitemid 38685338)
-
(2004)
Blood
, vol.103
, Issue.11
, pp. 4010-4022
-
-
Calabretta, B.1
Perrotti, D.2
-
2
-
-
33845444046
-
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
-
DOI 10.1056/NEJMoa062867
-
BJ Druker F Guilhot SG O'Brien 2006 Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia N Engl J Med 355 2408 2417 10.1056/NEJMoa062867 17151364 1:CAS:528:DC%2BD28Xht12ntrzM (Pubitemid 44903745)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.23
, pp. 2408-2417
-
-
Druker, B.J.1
Guilhot, F.2
O'Brien, S.G.3
Gathmann, I.4
Kantarjian, H.5
Gattermann, N.6
Deininger, M.W.N.7
Silver, R.T.8
Goldman, J.M.9
Stone, R.M.10
Cervantes, F.11
Hochhaus, A.12
Powell, B.L.13
Gabrilove, J.L.14
Rousselot, P.15
Reiffers, J.16
Cornelissen, J.J.17
Hughes, T.18
Agis, H.19
Fischer, T.20
Verhoef, G.21
Shepherd, J.22
Saglio, G.23
Gratwohl, A.24
Nielsen, J.L.25
Radich, J.P.26
Simonsson, B.27
Taylor, K.28
Baccarani, M.29
So, C.30
Letvak, L.31
Larson, R.A.32
more..
-
3
-
-
25444488489
-
Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia
-
DOI 10.1158/0008-5472.CAN-05-0076
-
DJ Barnes D Palaiologou E Panousopoulou 2005 Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia Cancer Res 65 8912 8919 10.1158/0008-5472.CAN-05-0076 16204063 1:CAS:528:DC%2BD2MXhtVKiu73J (Pubitemid 41377381)
-
(2005)
Cancer Research
, vol.65
, Issue.19
, pp. 8912-8919
-
-
Barnes, D.J.1
Palaiologou, D.2
Panousopoulou, E.3
Schultheis, B.4
Yong, A.S.M.5
Wong, A.6
Pattacini, L.7
Goldman, J.M.8
Melo, J.V.9
-
4
-
-
34249988828
-
Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells
-
DOI 10.1182/blood-2006-06-032490
-
H Modi T McDonald S Chu 2007 Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells Blood 109 5411 5421 10.1182/blood-2006-06-032490 17347407 1:CAS:528:DC%2BD2sXmslOrsbY%3D (Pubitemid 46890564)
-
(2007)
Blood
, vol.109
, Issue.12
, pp. 5411-5421
-
-
Modi, H.1
McDonald, T.2
Chu, S.3
Yee, J.-K.4
Forman, S.J.5
Bhatia, R.6
-
6
-
-
23044458596
-
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: A study by the GIMEMA working party on chronic myeloid leukemia
-
DOI 10.1200/JCO.2005.05.531
-
S Soverini G Martinelli G Rosti 2005 ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia J Clin Oncol 23 4100 4109 10.1200/JCO.2005.05.531 15867198 1:CAS:528:DC%2BD2MXmt1emu7Y%3D (Pubitemid 46211315)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.18
, pp. 4100-4109
-
-
Soverini, S.1
Martinelli, G.2
Rosti, G.3
Bassi, S.4
Amabile, M.5
Poerio, A.6
Giannini, B.7
Trabacchi, E.8
Castagnetti, F.9
Testoni, N.10
Luatti, S.11
De Vivo, A.12
Cilloni, D.13
Izzo, B.14
Fava, M.15
Abruzzese, E.16
Alberti, D.17
Pane, F.18
Saglio, G.19
Baccarani, M.20
more..
-
7
-
-
33646132293
-
The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression
-
16378690 1:CAS:528:DC%2BD28XktVyjtbY%3D
-
B Carpenter C Mackay A Alnabulsi 2006 The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression Biochim Biophys Acta 1765 85 100 16378690 1:CAS:528:DC%2BD28XktVyjtbY%3D
-
(2006)
Biochim Biophys Acta
, vol.1765
, pp. 85-100
-
-
Carpenter, B.1
MacKay, C.2
Alnabulsi, A.3
-
8
-
-
2942623743
-
HnRNP K: One protein multiple processes
-
DOI 10.1002/bies.20048
-
K Bomsztyk O Denisenko J Ostrowski 2004 HnRNP K: one protein multiple processes Bioessays 26 629 638 10.1002/bies.20048 15170860 1:CAS:528: DC%2BD2cXltlGjtb0%3D (Pubitemid 38758340)
-
(2004)
BioEssays
, vol.26
, Issue.6
, pp. 629-638
-
-
Bomsztyk, K.1
Denisenko, O.2
Ostrowski, J.3
-
9
-
-
0036124398
-
HnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis
-
DOI 10.1128/MCB.22.7.2255-2266.2002
-
A Iervolino G Santilli R Trotta C Guerzoni V Cesi A Bergamaschi C Gambacorti-Passerini B Calabretta D Perrotti 2002 hnRNP A1 Nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis Mol Cell Biol 22 2255 2266 10.1128/MCB.22.7.2255-2266.2002 11884611 1:CAS:528:DC%2BD38Xit1Kit78%3D (Pubitemid 34224631)
-
(2002)
Molecular and Cellular Biology
, vol.22
, Issue.7
, pp. 2255-2266
-
-
Iervolino, A.1
Santilli, G.2
Trotta, R.3
Guerzoni, C.4
Cesi, V.5
Bergamaschi, A.6
Gambacorti-Passerini, C.7
Calabretta, B.8
Perrotti, D.9
-
10
-
-
2342467457
-
Translational regulation by the p210 BCR/ABL oncoprotein
-
DOI 10.1038/sj.onc.1207543
-
P Danilo C Bruno 2004 Translational regulation by the p210 BCR/ABL oncoprotein Oncogene 23 3222 3229 10.1038/sj.onc.1207543 1:CAS:528: DC%2BD2cXjtFOmsbw%3D (Pubitemid 38638834)
-
(2004)
Oncogene
, vol.23
, Issue.18
, pp. 3222-3229
-
-
Perrotti, D.1
Calabretta, B.2
-
11
-
-
28944446040
-
HnRNP K: An HDM2 target and transcriptional coactivator of p53 in response to DNA damage
-
DOI 10.1016/j.cell.2005.09.032, PII S009286740501038X
-
A Moumen P Masterson MJ O'Connor 2005 HnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage Cell 123 1065 1078 10.1016/j.cell.2005.09.032 16360036 1:CAS:528:DC%2BD28XptVOl (Pubitemid 41785421)
-
(2005)
Cell
, vol.123
, Issue.6
, pp. 1065-1078
-
-
Moumen, A.1
Masterson, P.2
O'Connor, M.J.3
Jackson, S.P.4
-
12
-
-
0036276219
-
C-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs
-
DOI 10.1128/MCB.22.13.4535-4543.2002
-
A Ostareck-Lederer DH Ostareck C Cans 2002 c-src-Mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs Mol Cell Biol 22 4535 4543 10.1128/MCB.22.13.4535-4543.2002 12052863 1:CAS:528:DC%2BD38Xks1yrsLo%3D (Pubitemid 34620391)
-
(2002)
Molecular and Cellular Biology
, vol.22
, Issue.13
, pp. 4535-4543
-
-
Ostareck-Lederer, A.1
Ostareck, D.H.2
Cans, C.3
Neubauer, G.4
Bomsztyk, K.5
Superti-Furga, G.6
Hentze, M.W.7
-
13
-
-
33745813515
-
Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia
-
10.1016/j.leukres.2005.12.028 16507320 1:CAS:528:DC%2BD28XntV2gurg%3D
-
G-R Ruan Y-Z Qin S-S Chen J-L Li X Ma Y Chang Y-Z Wang J-Y Fu Y-R Liu 2006 Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia Leuk Res 30 1159 1165 10.1016/j.leukres.2005.12.028 16507320 1:CAS:528:DC%2BD28XntV2gurg%3D
-
(2006)
Leuk Res
, vol.30
, pp. 1159-1165
-
-
Ruan, G.-R.1
Qin, Y.-Z.2
Chen, S.-S.3
Li, J.-L.4
Ma, X.5
Chang, Y.6
Wang, Y.-Z.7
Fu, J.-Y.8
Liu, Y.-R.9
-
14
-
-
33845525384
-
Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia
-
DOI 10.1038/sj.leu.2404463, PII 2404463
-
M Pocaly V Lagarde G Etienne J-A Ribeil S Claverol M Bonneu F Moreau-Gaudry V Guyonnet-Duperat O Hermine JV Melo M Dupouy B Turcq F-X Mahon J-M Pasquet 2007 Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia Leukemia 21 93 101 10.1038/sj.leu.2404463 17109025 1:CAS:528:DC%2BD28XhtlSqurrK (Pubitemid 44921840)
-
(2007)
Leukemia
, vol.21
, Issue.1
, pp. 93-101
-
-
Pocaly, M.1
Lagarde, V.2
Etienne, G.3
Ribeil, J.-A.4
Claverol, S.5
Bonneu, M.6
Moreau-Gaudry, F.7
Guyonnet-Duperat, V.8
Hermine, O.9
Melo, J.V.10
Dupouy, M.11
Turcq, B.12
Mahon, F.-X.13
Pasquet, J.-M.14
-
15
-
-
11244272124
-
The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression
-
DOI 10.1182/blood-2004-04-1242
-
T Kichiro YK Jun T Eiji 2005 The Jab1/cop9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression Blood 105 775 783 10.1182/blood-2004-04-1242 1:CAS:528: DC%2BD2MXltlGnuw%3D%3D (Pubitemid 40070765)
-
(2005)
Blood
, vol.105
, Issue.2
, pp. 775-783
-
-
Tomoda, K.1
Kato, J.-Y.2
Tatsumi, E.3
Takahashi, T.4
Matsuo, Y.5
Yoneda-Kato, N.6
-
16
-
-
14644425319
-
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia
-
DOI 10.1038/nrc1567
-
R Ren 2005 Mechanism of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia Nat Rev Cancer 5 3 172 183 10.1038/nrc1567 15719031 1:CAS:528:DC%2BD2MXhslSnt7g%3D (Pubitemid 40314949)
-
(2005)
Nature Reviews Cancer
, vol.5
, Issue.3
, pp. 172-183
-
-
Ren, R.1
-
17
-
-
33646564358
-
Loss of p53 impedes the antileukemic response to BCR-ABL inhibition
-
DOI 10.1073/pnas.0602402103
-
HG Wendel E Stanchina E Cepero 2006 Loss of p53 impedes the antileukemic response to BCR-ABL inhibition PNAS 103 7444 7449 10.1073/pnas.0602402103 16651519 1:CAS:528:DC%2BD28XkslOrt7o%3D (Pubitemid 43727852)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.19
, pp. 7444-7449
-
-
Wendel, H.-G.1
De Stanchina, E.2
Cepero, E.3
Ray, S.4
Emig, M.5
Fridman, J.S.6
Veach, D.R.7
Bornmann, W.G.8
Clarkson, B.9
McCombie, W.R.10
Kogan, S.C.11
Hochhaus, A.12
Lowe, S.W.13
-
18
-
-
33749370720
-
Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer
-
DOI 10.1038/sj.bjc.6603349, PII 6603349
-
B Carpenter M McKay SR Dundas 2006 Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer Br J Cancer 95 921 927 10.1038/sj.bjc.6603349 16953238 1:CAS:528:DC%2BD28XhtVans7nI (Pubitemid 44498109)
-
(2006)
British Journal of Cancer
, vol.95
, Issue.7
, pp. 921-927
-
-
Carpenter, B.1
Mckay, M.2
Dundas, S.R.3
Lawrie, L.C.4
Telfer, C.5
Murray, G.I.6
-
19
-
-
0036340784
-
BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2
-
10.1038/ng791 11753385 1:CAS:528:DC%2BD38XislajsA%3D%3D
-
D Perrotti V Cesi R Trotta 2002 BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2 Nat Genet 30 48 58 10.1038/ng791 11753385 1:CAS:528:DC%2BD38XislajsA%3D%3D
-
(2002)
Nat Genet
, vol.30
, pp. 48-58
-
-
Perrotti, D.1
Cesi, V.2
Trotta, R.3
-
20
-
-
33644755496
-
AMAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation
-
DOI 10.1182/blood-2005-09-3732
-
M Notari P Neviani R Santhanam BW Blaser J-S Chang A Galietta AE Willis DC Roy MA Caligiuri G Marcucci D Perrotti 2006 AMAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation Blood 107 2507 2516 10.1182/blood-2005-09-3732 16293596 1:CAS:528:DC%2BD28XisFOju7w%3D (Pubitemid 43345575)
-
(2006)
Blood
, vol.107
, Issue.6
, pp. 2507-2516
-
-
Notari, M.1
Neviani, P.2
Santhanam, R.3
Blaser, B.W.4
Chang, J.-S.5
Galietta, A.6
Willis, A.E.7
Roy, D.C.8
Caligiuri, M.A.9
Marcucci, G.10
Perrotti, D.11
-
21
-
-
42449146501
-
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy
-
DOI 10.1038/leu.2008.27, PII LEU200827
-
JA McCubrey LS Steelman SL Abrams FE Bertrand DE Ludwig J Bäsecke M Libra F Stivala M Milella A Tafuri P Lunghi A Bonati AM Martelli 2008 Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy Leukemia 22 708 722 10.1038/leu.2008.27 18337766 1:CAS:528:DC%2BD1cXks12rtbo%3D (Pubitemid 351565619)
-
(2008)
Leukemia
, vol.22
, Issue.4
, pp. 708-722
-
-
McCubrey, J.A.1
Steelman, L.S.2
Abrams, S.L.3
Bertrand, F.E.4
Ludwig, D.E.5
Basecke, J.6
Libra, M.7
Stivala, F.8
Milella, M.9
Tafuri, A.10
Lunghi, P.11
Bonati, A.12
Martelli, A.M.13
-
22
-
-
0026539931
-
The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product
-
10.1126/science.1411546 1411546 1:CAS:528:DyaK3sXkvV2rtb0%3D
-
CM Crews A Alessandrini RL Erikson 1992 The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product Science 258 478 480 10.1126/science.1411546 1411546 1:CAS:528:DyaK3sXkvV2rtb0%3D
-
(1992)
Science
, vol.258
, pp. 478-480
-
-
Crews, C.M.1
Alessandrini, A.2
Erikson, R.L.3
-
23
-
-
0028293931
-
Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1
-
8157000 1:CAS:528:DyaK2cXksFarurs%3D
-
DR Alessi Y Saito DG Campbell P Cohen G Sithanandam U Rapp A Ashworth CJ Marshall S Cowley 1994 Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1 EMBO J 13 1610 1619 8157000 1:CAS:528: DyaK2cXksFarurs%3D
-
(1994)
EMBO J
, vol.13
, pp. 1610-1619
-
-
Alessi, D.R.1
Saito, Y.2
Campbell, D.G.3
Cohen, P.4
Sithanandam, G.5
Rapp, U.6
Ashworth, A.7
Marshall, C.J.8
Cowley, S.9
-
24
-
-
0028277844
-
Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras
-
DOI 10.1016/0896-6273(94)90438-3
-
LB Rosen DD Ginty MJ Weber ME Greenberg 1994 Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras Neuron 12 1207 1221 10.1016/0896-6273(94)90438-3 8011335 1:CAS:528:DyaK2cXlslKjsLw%3D (Pubitemid 24186790)
-
(1994)
Neuron
, vol.12
, Issue.6
, pp. 1207-1221
-
-
Rosen, L.B.1
Ginty, D.D.2
Weber, M.J.3
Greenberg, M.E.4
-
25
-
-
0028228616
-
Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
-
DOI 10.1016/0092-8674(94)90133-3
-
S Cowley H Paterson P Kemp CJ Marshall 1994 Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells Cell 77 841 852 10.1016/0092-8674(94)90133-3 7911739 1:CAS:528:DyaK2cXltVGhs7g%3D (Pubitemid 24187682)
-
(1994)
Cell
, vol.77
, Issue.6
, pp. 841-852
-
-
Cowley, S.1
Paterson, H.2
Kemp, P.3
Marshall, C.J.4
-
26
-
-
0028170210
-
A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)
-
8106507 1:CAS:528:DyaK2cXjtFGit78%3D
-
CJ Vlahos WF Matter KY Hui RF Brown 1994 A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) J Biol Chem 269 5241 5248 8106507 1:CAS:528:DyaK2cXjtFGit78%3D
-
(1994)
J Biol Chem
, vol.269
, pp. 5241-5248
-
-
Vlahos, C.J.1
Matter, W.F.2
Hui, K.Y.3
Brown, R.F.4
-
27
-
-
13344295097
-
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
-
DOI 10.1038/379645a0
-
N Meydan T Grunberger H Dadi 1996 Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor Nature 379 645 648 10.1038/379645a0 8628398 1:CAS:528:DyaK28XhtFKru7Y%3D (Pubitemid 26053453)
-
(1996)
Nature
, vol.379
, Issue.6566
, pp. 645-648
-
-
Meydan, N.1
Grunberger, T.2
Dadi, H.3
Shahar, M.4
Arpaia, E.5
Lapidot, Z.6
Leeder, J.S.7
Freedman, M.8
Cohen, A.9
Gazit, A.10
Levitzki, A.11
Roifman, C.M.12
-
28
-
-
0041737454
-
Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia
-
DOI 10.1182/blood-2003-01-0137
-
S Meshinchi DL Stirewalt TA Alonzo Q Zhang DA Sweetser WG Woods 2003 Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia Blood 102 1474 1479 10.1182/blood-2003-01-0137 12702504 1:CAS:528:DC%2BD3sXmsFWktL0%3D (Pubitemid 36988059)
-
(2003)
Blood
, vol.102
, Issue.4
, pp. 1474-1479
-
-
Meshinchi, S.1
Stirewalt, D.L.2
Alonzo, T.A.3
Zhang, Q.4
Sweetser, D.A.5
Woods, W.G.6
Bernstein, I.D.7
Arceci, R.J.8
Radich, J.P.9
-
29
-
-
22944432512
-
Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effects
-
DOI 10.2174/1381612054546842
-
M Milella CM Precupanu C Gregorj MR Ricciardi MT Petrucci SM Kornblau A Tafuri M Andreeff 2005 Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effects Curr Pharm Des 11 2779 2795 10.2174/1381612054546842 16101455 1:CAS:528:DC%2BD2MXmvVyrsLo%3D (Pubitemid 41051884)
-
(2005)
Current Pharmaceutical Design
, vol.11
, Issue.21
, pp. 2779-2795
-
-
Milella, M.1
Precupanu, C.M.2
Gregorj, C.3
Ricciardi, M.R.4
Petrucci, M.T.5
Kornblau, S.M.6
Tafuri, A.7
Andreeff, M.8
-
30
-
-
0035051044
-
Sensitivity to the abl inhibitor STI571 in fresh leukaemic cells obtained from chronic myelogenous leukaemia patients in different stages of disease
-
DOI 10.1046/j.1365-2141.2001.02653.x
-
C Gambacorti-Passerini R Barni E Marchesi M Verga M Rossi F Rossi P Pioltelli E Pogliani M Corneo 2001 Sensitivity of the abl inhibitor STI571 in fresh leukaemic cells obtained from chronic myelogenous leukaemia patients in different stages of the disease Br J Haematol 112 972 974 10.1046/j.1365-2141. 2001.02653.x 11298594 1:CAS:528:DC%2BD3MXjsV2ru7c%3D (Pubitemid 32322924)
-
(2001)
British Journal of Haematology
, vol.112
, Issue.4
, pp. 972-974
-
-
Gambacorti-Passerini, C.1
Barni, R.2
Marchesi, E.3
Verga, M.4
Rossi, F.5
Rossi, F.6
Pioltelli, P.7
Pogliani, E.8
Corneo, G.M.9
-
31
-
-
33745057158
-
STAT5 signaling is required for the efficient induction and maintenance of CMLin mice
-
DOI 10.1182/blood-2005-10-4110
-
D Ye N Wolff L Li 2006 STAT5 signaling is required for the efficient induction and maintenance of CML in mice Blood 107 4917 4925 10.1182/blood-2005-10-4110 16522816 1:CAS:528:DC%2BD28XlvFCgtLw%3D (Pubitemid 43882645)
-
(2006)
Blood
, vol.107
, Issue.12
, pp. 4917-4925
-
-
Ye, D.1
Wolff, N.2
Li, L.3
Zhang, S.4
Ilaria Jr., R.L.5
|